Pediatric allogeneic stem cell transplant patients have high rates of post-transplant toxicities.
Reduced toxicity is not less toxic than myeloablative conditioning in this population.
Patient age ≥ 12 years is a significant risk factor for early post-transplant toxicities.
Performance score < 90 and ≥3 post-transplant toxicities are associated with increased mortality.